<DOC>
	<DOCNO>NCT02757521</DOCNO>
	<brief_summary>Investigators study approximately 64 patient Treatment-Resistant Bipolar Depressive Disorder , define failure least 1 antidepressant current depressive episode 2 lifetime medication failure . The study last approximately 6 8 week , involve randomization one two treatment group receive 3 one hour long inhalation treatment week .</brief_summary>
	<brief_title>Nitrous TRD Bipolar Depression</brief_title>
	<detailed_description>Investigators study approximately 64 patient Treatment-Resistant Bipolar Depressive Disorder , define failure least 1 antidepressant current depressive episode 2 lifetime medication failure . The study last approximately 6 8 week , involve randomization one two treatment group receive 3 one hour long inhalation treatment week . Post-treatment assessment follow inhalation treatment conduct 1 week 2 week follow final inhalation treatment . Patients randomized Second Stage study , involve treatment post-treatment schedule First Stage detail .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Nitrous Oxide</mesh_term>
	<criteria>Adults 1865 year age Treatmentresistant bipolar depressive disorder without psychosis MADRS baseline score &gt; 20 . All patient must history serumverified ( time entry study ) mood stabilizer [ lithium 0.51.2mEq/L ; valproic acid , 50125mcg/ml ] 4 week prior entry study remain mood stabilizer course trial . Further , subject fail two adequate dose/duration antidepressant course lifetime , include one current depressive episode ( verified Antidepressant Treatment History Form ) . Good command English language Schizophrenia Schizoaffective disorder Obsessivecompulsive disorder panic disorder Active recent substance abuse dependence ( remission least 1 year prior study ; exception = nicotine use disorder ) A diagnosis personality disorder may interfere patient 's ability improve nitrous oxide determine study investigator Acute medical illness may pose subject risk nitrous oxide administration ( neurological disorder medical disorder include dementia , stroke , encephalopathy , Parkinson 's Disease , brain tumor , multiple sclerosis , seizure disorder , severe cardiac disease , disease know affect drug metabolism excretion , i.e . renal liver disease ) per P.I . discretion Active suicidal intention ( inability contract safety ) Active psychotic symptom Patients significant pulmonary disease and/or require supplemental oxygen Contraindication use nitrous oxide : pneumothorax ; bowel obstruction ; middle ear occlusion ; elevate intracranial pressure ; chronic cobalamin and/or folate deficiency treat folic acid vitamin B12 ; pregnant patient ; breastfeed woman ; previous administration NMDAreceptor antagonist ( e.g. , ketamine ) ; current electroconvulsive therapy treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bipolar Depressive Disorder</keyword>
	<keyword>Treatment- Resistant Bipolar Disorder</keyword>
	<keyword>Nitrous Oxide</keyword>
</DOC>